Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment
NCT00827047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2016-04-01
Summary
Total hemihepatic vascular exclusion(THHVE),completely isolates the right or left hemiliver ipsilateral to the lesion that requires resection from the systemic circulation,has the advantage of preventing backflow hemorrhage or air embolism without having to resort to caval blood flow interruption of THVE.This study is to evaluate if THHVE can raduce bleeding,reduce the incidence of complications and improve the patient's free survival and overall survival compared with hemihepatic vascular clamping and Pringle maneuver.
Conditions
Interventions
- PROCEDURE
-
Total hemihepatic vascular exclusion
A long vascular clamp is inserted along the midline of the anterior surface of the vena cava,proceed cranially up to the space between the right and the middle hepatic vein trunks. Two tapes are seized with the clamp passing between the anterior surface of the IVC and the liver parenchyma.One tape is use to pass around the hepatic parenchyma for occlusion of the bleeding from the remnant liver;the other is used to loop the right (or left )hepatic vein trunk and short hepatic vein,as well as inferior right hepatic vein,if present. Selectively interrupts the arterial and portal inflow to the part of the liver (right or left hemiliver)ipsilateral to the lesion that requires resection.Thus total hemihepatic vascular exclusion is achieved.
- PROCEDURE
-
Hemihepatic vascular Clamping
Selectively interrupts the arterial and portal inflow to the part of the liver (right or left hemiliver)ipsilateral to the lesion that requires resection. Selective clamping can be achieved after carefully dissecting the right from the left hilar branches or after inserting a clamp between the right and left hilar branches without prior hilar dissection and looping the right or left portal structures with a tape.
- PROCEDURE
-
Pringle's Maneuver
Hepatic pedicle clamping is performed by encircling the hepatoduodenal ligament with a tape and then applying a tourniquet or a vascular clamp until the pulse in the hepatic artery disappears distally.
Sponsors & Collaborators
-
Eastern Hepatobiliary Surgery Hospital
lead OTHER
Principal Investigators
-
Feng Shen, M.D · Eastern Hepatobiliary Surgery Hospital, Second Military Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-12-31
- Completion
- 2012-12-31
Countries
- China
Study Locations
More Related Trials
-
Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
NCT00479050 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC
NCT00834158 ·Status: COMPLETED ·Phase: NA
-
Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus
NCT01600196 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion
NCT02728219 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
NCT04025437 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison
NCT04823715 ·Status: COMPLETED
-
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
NCT02755311 ·Status: UNKNOWN ·Phase: PHASE3
-
Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion
NCT00826384 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC
NCT02563158 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
NCT00849264 ·Status: COMPLETED ·Phase: PHASE2
-
Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion
NCT00501813 ·Status: UNKNOWN ·Phase: PHASE3
-
Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma
NCT01860222 ·Status: UNKNOWN ·Phase: NA
-
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
NCT06462742 ·Status: RECRUITING
-
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
NCT01858207 ·Status: UNKNOWN ·Phase: PHASE2
-
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
NCT02587884 ·Status: UNKNOWN ·Phase: PHASE1
-
Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas
NCT04172194 ·Status: COMPLETED
-
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
NCT06248528 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma
NCT01713244 ·Status: UNKNOWN ·Phase: NA
-
Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis
NCT01350206 ·Status: UNKNOWN ·Phase: PHASE4
-
Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma
NCT07281664 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma
NCT00820157 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis
NCT04947826 ·Status: UNKNOWN ·Phase: PHASE2
-
Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma
NCT00652587 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
NCT02138981 ·Status: UNKNOWN ·Phase: PHASE4
-
RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
NCT02964260 ·Status: UNKNOWN ·Phase: NA